Pfizer (PFE) has issued an announcement.
Pfizer Inc. has expanded its Board of Directors with the addition of Cyrus Taraporevala, who will also serve on the Audit and Compensation Committees. Taraporevala’s depth of experience promises to strengthen the board’s expertise, offering shareholders and potential investors a cue of the company’s commitment to strong governance and strategic oversight. He will be compensated in line with Pfizer’s policies for non-employee directors, ensuring alignment with the company’s standards and practices.
Learn more about PFE stock on TipRanks’ Stock Analysis page.
